ABSTRACT: Bone morphogenetic protein (BMP)-2 and ibandronate (IB) decrease the femoral head deformity following ischemic osteonecrosis of the femoral head (ONFH). The purpose of this study was to determine the effects of BMP-2 and IB on the mineral content and nanoindentation properties of the bone following ONFH. ONFH was surgically induced in the femoral head of piglets. There were five groups: normal control, untreated, IB, BMP, and BMP þ IB (n ¼ 5/group). Backscattered electron imaging, Raman spectroscopy, and nanoindentation testing were performed. Both BMP and BMP þ IB groups showed calcium content in the trabecular bone similar to the normal group, while the IB and no-treatment groups showed a significant increase in the calcium content compared to the normal group. The carbonate content relative to phosphate was significantly increased in the IB and BMP þ IB groups (p < 0.01) compared to the normal group. No significant difference was found between the BMP and the normal group. The nanoindentation modulus of the bone in the IB group was significantly increased compared to the normal group (p < 0.05). No significant differences were observed between the BMP and BMP þ IB groups compared to the normal group. The nanoindentation hardness measurements in the IB group were also significantly increased compared to the BMP and BMP þ IB groups (p < 0.05). In summary, trabecular bone treated with BMP or BMP þ IB had material properties comparable to normal bone whereas the bone in the IB group retained the increased mineral content and the nanoindentation hardness found in the necrotic bone. Hence, BMP or BMP þ IB better restores the normal mineral content and nanomechanical properties after ONFH than IB treatment alone. ß
Legg-Calv e-Perthes disease (LCPD) is a juvenile hip disorder attributed to a loss of blood flow to the bony epiphysis that causes osteonecrosis of the femoral head. The development of a permanent femoral head deformity is a common complication of LCPD, with 50% of the patients developing osteoarthritis before age 60. 1, 2 Due to a lack of availability of pathological specimens, an experimental model of osteonecrosis of the femoral head in piglets has been used to delineate the pathophysiology of juvenile ischemic osteonecrosis. [3] [4] [5] The model develops a moderate to severe flattening deformity similar to that seen in patients with LCPD.
Before the flattening deformity, the model has shown extensive cell death, increased mineral content, and microcracks in the necrotic bone. 6, 7 This is followed by extensive resorption of necrotic bone during the healing phase that has been shown to lead to deformity of the femoral head; for this reason, balancing bone formation, and resorption using biologic therapies to improve bone healing and to maintain the round shape of the femoral head during the healing process remains an attractive therapeutic option to explore.
Bisphosphonates and bone morphogenetic proteins (BMPs) have previously been used as treatment in experimental models of femoral head osteonecrosis. [8] [9] [10] [11] [12] [13] [14] Bone morphogenic proteins are potential therapeutic options that play a pivotal role in bone formation during bone development and fracture healing. [15] [16] [17] On the other hand, bisphosphonates are a class of drugs that bind to bone mineral in areas of bone turnover and decrease bone resorption. [18] [19] [20] [21] [22] Bisphosphonates and BMPs can be used for their respective anti-resorptive 23 and bone anabolic capabilities. 24 A combined therapy of bisphosphonate and BMP-2 has been shown to be beneficial in maintaining bone volume and supporting bone formation in the experimental animal model of osteonecrosis of the femoral head. 5, 11, 13, 14, 25 Femoral heads treated with ibandronate (IB) alone maintained bone volume with no new bone formation 11 whereas femoral heads treated with BMP-2 alone or in combination with ibandronate stimulated osteoblast differentiation and new bone formation 13 ( Fig. 1 ). However, little is known about the effects of these treatments on the mineral content, composition, and nanomechanical properties of the bone during bone healing following ischemic osteonecrosis. This information will be useful in developing the best biologic treatment to restore bone which can withstand microdamage accumulation and the femoral head deformity in long-term. In this study, femoral heads from previous studies that were either untreated or treated after ischemia induction with ibandronate (IB), BMP, or BMP þ IB were evaluated for their mineral content, composition, and nanomechanical properties. The purpose of this study was to determine the effects of treatment with bmp-2 and ibandronate, as single agents or as combined therapy, on the mineral content and nanomechanical properties of trabecular bone during the healing stage of ischemic osteonecrosis of the femoral head.
MATERIALS AND METHODS

Surgical Induction of Osteonecrosis
Femoral head samples from 20 male Duroc Yorkshire cross piglets of similar age and weight (5-8 weeks, 6-12 kg) that received surgical induction of osteonecrosis by the same surgeon were obtained from previously approved IACUC studies. To induce ischemic osteonecrosis of the femoral head, the ligamentum teres of the femoral head was transected and a ligature consisting of #1 Vicryl suture material (Ethicon Inc., Somerville, NJ) was placed tightly around the right femoral neck, as previously described. 3 The femoral heads were randomly treated at an early stage (1 week after ischemia induction when there is minimal deformity) with one of the following regimens (n ¼ 5/group): local intraosseous administration of ibandronate (IB), bmp-2 (BMP), or BMP þ IB where IB, BMP, or BMP þ IB was delivered using a 15-gauge intraosseous needle (EZ-IO; Vidacare, San Antonio, TX) in respective concentrations of 0.6 mg/0.6 ml for IB, 0.5 mg/ 0.5 ml for BMP, and combined for BMP þ IB. In addition, the unoperated left femoral heads of the animals in the no-treatment group (i.e., no treatment after the induction of osteonecrosis on the right femoral head) were used for the normal group. The mean weight and age of piglets in different groups were similar at the time of surgery with no statistical difference ( Table 1 ). All animals were euthanized 8 weeks post-surgical induction of osteonecrosis when revascularization, bone resorption, and the femoral head deformity are expected. 4, 26 At the time of euthanasia, animals were similarly aged. The mean weights of the groups were similar between all groups except for the BMP group and the IB group as BMP treated animals weighed more. The IB-treated group did have the lowest mean weight at the start of the experiment while the BMP treated group had the highest mean weight.
Histology
The proximal femora were retrieved and bisected into anterior and posterior halves using the anterior aspect of the ligamentum teres and the midpoint of the greater trochanter as landmarks and fixed in 10% neutral buffered formalin. After fixation, the posterior half was dehydrated in increasing grades of alcohol and embedded in methyl methacrylate (MMA) for sectioning using a sledge microtome. Thin sections were stained with McNeal tetrachrome and von Kossa stains using standard procedures as previously described 27 (Fig. 1a) . The anterior half of the femoral head was decalcified with ethylenediaminetetraacetic acid (EDTA) and processed for paraffin embedding and sectioning. Tissue sections from the anterior half were stained with hematoxylin and eosin (H&E) stains (Fig. 1b) .
Areas of revascularization were identified based on the presence of blood vessels in the marrow space and the areas of new bone formation were identified based on osteoblasts on the trabecular surface with osteoid deposition. Digital images of a 5 mm 2 area were acquired from McNeal tetrachrome and von Kossa stained slides at 100Â magnification using BIOQUANT OSTEOIMAGER (BIOQUANT Image Analysis Corp, Nashville, TN) and analyzed using BIO-QUANT OSTEO software (version 16.1.60). The region included bone that was assessed for osteoid volume/bone volume, osteoid surface/bone surface, osteoid surface (with osteoblast present)/bone surface, and osteoblast surface/bone surface. All indices were obtained using BIOQUANT OSTEO software.
Quantitative Backscattered Electron Imaging (qBEI) After sectioning of the MMA embedded blocks, the blocks were polished with increasing grades of silicon carbide paper (1,200, 2,400, and 4,000 grit). The blocks were rinsed ultrasonically in deionized water in between each polishing step. The blocks were polished sequentially with a 0.25 and 0.05 mm diamond slurry and carbon coated for SEM imaging. Backscattered electron images of the mid-epiphyseal region of the femoral head were obtained at a magnification of 50Â for all samples using a beam energy of 20 kV. The working distance was 15 mm. The images were used for quantifying distribution of mineralization in bone. Quantification for mineralization in bone has been previously described. 6, 28 Briefly, carbon, aluminum, and hydroxyapatite were used as standards to calibrate a bone mineral density distribution (BMDD) from a backscattered electron signal. A calibration line was drawn to correlate the respective gray level values and atomic numbers for each standard. The gray levels were then converted to weight percent of calcium based on the molecular formula of hydroxyapatite, and a BMDD in terms of the weight percent of calcium was generated. The weighted mean of the distribution (CaMean) and the weight percent value with the most frequency (CaPeak) were obtained from each BMDD.
Raman Spectroscopy
After qBEI imaging, the carbon coat was removed with 4,000 grit silicon carbide paper. Trabecular bone from revascularized regions was identified with the optical microscope on the Raman Spectroscopy system using corresponding McNeal slides. The compositional characterization of the trabecular bone was performed with the microspot Raman spectroscopy (DXR, Thermo Scientific, 780 nm, 100 mW, 50 mm slit, 100 Â objective, 30 s exposure). Thirty spectra per location within the trabeculae of normal, necrotic, and treated groups (IB, BMP, and BMP þ IB) were recorded between 400 and 2,000 cm À1 . Across each trabecular cross-section, at least five locations were analyzed avoiding porosities from lacunae. From the spectra, the peak areas of phosphate n 1 PO 4 (930-980 cm À1 ), carbonate (1,050-1,100 cm À1 ), and matrix collagen amide I (1,620-1,700 cm À1 ) were measured. Ratios of these peak areas resulted in measures of carbonate to phosphate, phosphate to amide I, and carbonate to amide I.
Nanoindentation
Revascularized regions within the epiphysis were identified based on corresponding histological sections. Trabecular bone was identified through an optical microscope, and an exposed area of trabecular bone within the revascularized region was selected for indentation. A Hysitron Ubi-1 Nanoindenter (Hysitron, Minneapolis, MN) with a Berkovich tip was used for nanoindentation. The location for the indentation area was verified by view through the optical camera in the nanoindentation chamber that showed both the Berkovich tip and the region of interest. A bony structure within the revascularized region was identified. The exact location of the indenter tip on the trabecular bone; however, could not be confirmed in relation to its porous structures such as the canaliculi and the lacunae. Indentation in the embedding material was excluded based on the measured moduli as previously described. 7 Indentations with a reduced modulus above 7 GPa were used for analysis as lower moduli were indentations in the plastic embedding substrate. An area of at least 3,600 mm 2 was analyzed per femoral head. At least 30 indentations were analyzed in the area. The following loading function was performed for each indentation: (i) ramped to 500 mN at 50 mN/s; (ii) held for 5 s; and then (iii) unloaded at 50 mN/s. The unloading point of the loading curve was used for reduced modulus (i) and hardness (ii) calculations based on the Oliver-Pharr method. 29 The reduced modulus was calculated from
E r is defined as the reduced modulus, S as the slope of the most linear part of the upper portion of the unloading curve, and A c as the projected contact area of the Berkovich tip. For hardness, the values are calculated from
H is defined as the hardness, which is calculated by the maximum load, P m , divided by the projected contact area of the Berkovich tip.
Statistical Analysis
Peak area ratios of the carbonate (1,070 cm
À1
) to phosphate (961 cm À1 ), mineral (960 cm À1 ) to matrix (1,665 cm À1 ), and carbonate (1,070 cm À1 ) to amide I (1,665 cm À1 ) were averaged for the femoral heads and grouped under respective control and treatment groups. Similarly, the reduced modulus and hardness values from nanoindentation, and CaMean and CaPeak values from qBEI were averaged for each group. All data are presented as mean AE standard deviation. A one-way ANOVA was used to determine the overall difference among groups. If the difference was significant at p < 0.05, a post hoc Tukey honestly significant difference testing was performed to assess the significance between groups. A post hoc power analysis was performed. Power was set at 0.8 with a ¼ 0.05. The effect size was calculated based on the means from each group. These data were used to calculate the power and the minimum number of femoral heads needed for each group for a power of 0.8 (assuming the number of femoral heads per group was equal) using the statistical Age: A one-way ANOVA was used to determine the overall difference between groups. There was no statistical difference in the age at the beginning (p ¼ 0.085) or end (p ¼ 0.451) of the study. Weight: A one-way ANOVA was used to determine the overall difference between groups. There was no difference in weight at the beginning of the study (p ¼ 0.082). At the end of the study (p ¼ 0.009), a post hoc Tukey test revealed a significant difference between the BMP treated group and the IB treated group (p ¼ 0.007). The IB treated group did have the lowest mean weight at the start of the experiment while the BMP treated group had the highest mean weight.
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program G Ã Power (G Ã Power Version 3.1.9.2, Universitat Kiel, Germany).
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RESULTS
McNeal tetrachrome and von Kossa stained sections from the femoral heads revealed areas of revascularized tissue in the marrow space and evidence of bone formation. The normal, BMP, and BMP þ IB group, trabeculae were lined with osteoblasts indicating bone formation (Fig. 1a) . However, within the no treatment (necrotic) and ibandronate group, the areas containing revascularized tissue in the marrow space showed a lack of osteoblasts on the adjacent trabecular bone surface (Fig. 1a) . Histomorphometric assessment of the osteoid and osteoblast indices ( Table 2) revealed significantly more osteoid volume/bone volume in the BMP treated femoral heads compared to all other groups (p < 0.001), and the BMP þ IB group was significantly higher than the no treatment group (p ¼ 0.038). The BMP þ IB group had significantly more osteoid surface/bone surface than the no treatment (p ¼ 0.001) and IB groups (p ¼ 0.025), while the BMP group had significantly more osteoid surface/ bone surface than the no treatment group (p ¼ 0.006). When factoring the presence of osteoblasts, the BMP and BMP þ IB groups showed significantly more osteoblast surface with and without osteoid than the no treatment (p < 0.01) and IB-treated groups (p < 0.01).
We evaluated the mineral content distribution using backscattered electron microscopy (Fig. 2) . The bone mineral density distributions (BMDDs) were analyzed for calcium mean and calcium peak values. Data in Table 3 shows that mineral content distribution was significantly increased in the no treatment and IB groups. BMDD in the no treatment and IB groups had significantly increased mean calcium content (CaMean) (p ¼ 0.002) and frequency (CaPeak) (p ¼ 0.032) compared to the normal group, while the mean CaMean and CaPeak of the BMP and BMP þ IB groups were similar to the normal group.
Raman spectroscopy and nanoindentation were used to measure the compositional and mechanical properties of the trabecular bone, respectively. The carbonate content and mineral to matrix ratios were measured by Raman spectroscopy. The carbonate to phosphate ratios in the no treatment (p ¼ 0.001), IB (p ¼ 0.001), and BMP þ IB (p ¼ 0.003) groups were significantly higher than the normal group. No significant difference was observed between the BMP and the normal group (Fig. 3a) . The no treatment (p ¼ 0.007) and IB groups (p ¼ 0.003) had significantly higher carbonate to amide I ratio in comparison to the normal group whereas no significant difference was observed between the BMP, BMP þ IB, and the normal group (Fig. 3b) . The mineral to matrix ratios in the no treatment group (p ¼ 0.010) and the IB group (p ¼ 0.004) were significantly higher than the normal group. No significant difference was observed between the BMP, BMP þ IB, and the normal group (Fig. 3c) . Mechanical properties measured by nanoindentation showed only significant differences of increased moduli and hardness in the trabecular bone of the IB group compared to the normal group (p < 0.05) (Fig. 4) . Furthermore, a significantly increased hardness was found in the IB group compared to all other treatment groups (BMP and BMP þ IB) (p 0.02).
A post hoc power analysis revealed all except one variable (the reduced modulus) had a power above 0. 
DISCUSSION
This is the first study to our knowledge to investigate the effect of antiresorptive and anabolic agents on the material properties of trabecular bone following ischemic osteonecrosis of the immature femoral head. The local administration of BMP-2 following ischemic osteonecrosis has been shown previously to stimulate bone formation, while treatment with antiresorptive agents, such as bisphosphonates and RANKL inhibitor, 31 showed minimal new bone formation. This study shows that when a necrotic femoral head is treated with BMP-2 alone or in combination with ibandronate, its trabecular bone has comparable material properties to normal bone without leading to a significant increase in the mineral content or the nanomechanical properties as seen with the ibandronate treatment alone. Interestingly, when ibandronate is combined with BMP-2 treatment, the nanomechanical properties and mineral content are comparable to normal bone. This was supported by quantitative backscattered electron imaging that showed significantly increased calcium content in the IB treated-group compared to the normal group while the calcium content in the BMP and BMP þ IBtreated groups were comparable to the normal group. The increased mineral content was further supported by an increased mineral to matrix ratio in the no treatment and ibandronate groups measured by Raman spectroscopy. Collectively, new bone formation stimulated by BMP treatment provides comparable material properties to normal bone whereas IB and no-treatment groups have minimal new bone formation and retain abnormal material properties with increased mineral content.
Bisphosphonates are used to decrease bone resorption and maintain bone volume in postmenopausal osteoporosis [32] [33] [34] and Paget's disease 35 and has been used previously in animal models of osteonecrosis to prevent excessive resorption of necrotic bone. [8] [9] [10] While the use of ibandronate alone maintains bone volume after the induction of ischemic osteonecrosis by decreasing bone resorption, 36 the trabecular bone treated with ibandronate lacks remodeling of the necrotic bone and new bone formation. The trabecular microstructure of the BMP þ IB-treated group showed thicker trabeculae due to the appositional bone formation on the surface of the necrotic bone maintained by IB treatment, 13 thus, yielding a mixed distribution of mineral from newer and older trabecular bone. Decreased remodeling has been shown previously to increase the mineral content of bone treated with bisphosphonate in normal beagles 37 and osteoporotic patients. 38, 39 Similarly in this study, the mineral content was increased in trabecular bone treated with ibandronate. Additionally, necrotic trabecular bone without treatment also showed increased mineral content. In fact, necrotic bone in the femoral head has been analyzed previously using quantitative backscattered imaging where the mineral content was significantly increased compared with normal bone. 6 When trabecular bone is treated with BMP or a combination of BMP and IB, it had comparable material properties to normal bone.
The mineral composition of trabecular bone analyzed by Raman spectroscopy revealed increased carbonate-to-amide I and carbonate-to-phosphate ratios in the no treatment and IB groups. These groups have been shown to maintain necrotic bone with minimal bone formation. Necrotic bone that is maintained without any remodeling is older than normal bone that is continually modeled and remodeled in the normal developing femoral head. In fact, increased carbonate content has been linked to older bone. [40] [41] [42] 
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Furthermore, the mineral to matrix ratio was increased in the no treatment and IB groups where increased mineral-to-matrix ratios and crystallinity have been attributed to fracture risk. 43, 44 Additionally, increased carbonate-to-amide I and carbonate-to-phosphate ratios have been attributed to fracture risk in osteoporotic patients. 45 Trabecular bone treated with BMP or BMP þ IB showed comparable carbonate content and mineral to matrix ratios to normal bone where only the carbonate to phosphate ratio in the BMP þ IB group was significantly increased. Due to the minimal bone formation and remodeling in trabecular bone treated with ibandronate 11 and the increase in bone formation in the trabecular bone treated with BMP and/or BMP þ IB, 13 it is reasonable to speculate that increased bone formation after ischemic osteonecrosis improves the bone compositional parameters that have been linked to subchondral and compression fracture risk of the femoral head. Conceivably, the repair process of necrotic bone following BMP treatment could potentially involve trabecular bone that is partially removed and replaced with new bone tissue benefiting composition and associated material properties of the trabecular bone.
We believe the increased mineral content in the trabecular bone treated with ibandronate produced increased nanomechanical properties measured by nanoindentation in the IB group. Oral ibandronate therapy has been linked to increased hardness in osteoporotic patients 46 and stiffer trabecular bone after bisphosphonate use in patients with severely suppressed bone turnover. 47 Interestingly, the combinatory effect of ibandronate and BMP led to no significant increase in nanomechanical properties. Few studies have investigated the nanomechanical properties of bone following treatment with BMP-2. 48, 49 Unfortunately, these studies were limited to the calvaria where BMP and biomaterials were used to promote and support bone formation. However, similar nanomechanical properties were obtained when compared to the host calvaria bone. 49 Our study involved trabecular bone treated with BMP and/or ibandronate without the support of other biomaterials and within the femoral head as opposed to the calvaria. Understanding of how the nanomechanical properties can be extrapolated to the whole mechanical strength and fracture risk of the femoral head is limited. Nonetheless, we believe trabecular bone treated with BMP and BMP þ IB was more heterogeneous and provided similar nanomechanical properties to normal bone.
This study does have some limitations. While qBEI assessed at a much larger area of tissue volume (!50 mm 2 ) within the mid-epiphysis, Raman and nanoindentation measurements were captured at smaller scales (<10,000 mm 2 ). Nonetheless, measurements were performed in revascularized regions of the femoral head, and the Raman and nanomechanical measurements were indicative of pooled measurements across a trabeculae. The measurements were performed in a similar location for all samples avoiding measurements in the embedding material. Since we have small sample size (n ¼ 5 per group), multiple comparisons are not adjusted. The post hoc power analysis indicates we need to have at least six animals per group to be adequately powered for the reduced modulus without adjusting for multiple group comparisons. Assessment of the material properties was limited to one time point; later time points may be informative in assessing bone formation that may be delayed in the IB-treated group. The 8-week time point was chosen since a moderate to severe femoral head deformity develops in this large animal model and prevention of the deformity is the primary outcome of this study as it is a clinical important outcome. In a clinical setting, the goal of treatment is also to prevent the deformity thus treatment should begin as early as possible before a deformity develops. In our clinical experience, about 40% of patients present at an early stage of ischemic osteonecrosis of the femoral head before any significant deformity is seen. In addition, macro scale measurements of mechanical properties may provide an overall assessment of the mechanical properties of bone in response to loading and its ability to resist subchondral fracture in the femoral head. Finally, activity levels of the piglets were not monitored.
CONCLUSIONS
In conclusion, treatment of necrotic femoral head with bone anabolic and anti-resorptive agents following ischemic osteonecrosis produces significantly different material properties of bone. The findings show that BMP-2 and combined BMP-2 and ibandronate treatment better normalize the material properties of bone than ibandronate treatment alone following ischemic osteonecrosis.
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